BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37715354)

  • 1. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy.
    Frustaci A; Borghetti V; Pentiricci S; Verardo R; Scialla R; Russo MA
    ESC Heart Fail; 2023 Dec; 10(6):3710-3713. PubMed ID: 37715354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body.
    Oikawa M; Sakamoto N; Kobayashi A; Suzuki S; Yoshihisa A; Yamaki T; Nakazato K; Suzuki H; Saitoh S; Kiko Y; Nakano H; Hayashi T; Kimura A; Takeishi Y
    BMC Cardiovasc Disord; 2016 May; 16():83. PubMed ID: 27160240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence of Fabry Disease Among Turkish Patients with Non-Obstructive Hypertrophic Cardiomyopathy: Insights from a Screening Study.
    Barman HA; İkitimur B; Kılıçkıran Avcı B; Durmaz E; Atıcı A; Aslan S; Ceylaner S; Karpuz H
    Balkan Med J; 2019 Oct; 36(6):354-358. PubMed ID: 31446751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
    Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
    Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in left atrial function, left ventricle remodeling, and fibrosis after septal myectomy for obstructive hypertrophic cardiomyopathy.
    Tang B; Song Y; Yang Q; Cui H; Ji K; Zhao S; Wang S
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1828-1834.e4. PubMed ID: 32778464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Clinical Characteristics of Fabry Disease in Chinese Patients With Hypertrophic Cardiomyopathy.
    Xiao Y; Sun Y; Tian T; Wang TJ; Zhao RX; Zhang Y; Wang LP; Liu YX; Lu CX; Zhou XL; Yang WX
    Am J Med Sci; 2021 Sep; 362(3):260-267. PubMed ID: 34266644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
    Maron MS; Xin W; Sims KB; Butler R; Haas TS; Rowin EJ; Desnick RJ; Maron BJ
    Am J Med; 2018 Feb; 131(2):200.e1-200.e8. PubMed ID: 28943383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
    Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
    Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
    Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
    J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative Diagnosis of Anderson-Fabry Disease in Patients With Obstructive Hypertrophic Cardiomyopathy Undergoing Surgical Myectomy.
    Cecchi F; Iascone M; Maurizi N; Pezzoli L; Binaco I; Biagini E; Fibbi ML; Olivotto I; Pieruzzi F; Fruntelata A; Dorobantu L; Rapezzi C; Ferrazzi P
    JAMA Cardiol; 2017 Oct; 2(10):1147-1151. PubMed ID: 28793143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Novel GLA Gene Mutation, p.Ile239Met, in Fabry Disease With a Predominant Cardiac Phenotype.
    Csányi B; Hategan L; Nagy V; Obál I; Varga ET; Borbás J; Tringer A; Eichler S; Forster T; Rolfs A; Sepp R
    Int Heart J; 2017 May; 58(3):454-458. PubMed ID: 28496025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination.
    Hong J; Schaff HV; Ommen SR; Abel MD; Dearani JA; Nishimura RA
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1044-8. PubMed ID: 26724969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained improvement after combined anterior mitral valve leaflet retention plasty and septal myectomy in preventing systolic anterior motion in hypertrophic obstructive cardiomyopathy in children.
    Delmo Walter EM; Siniawski H; Hetzer R
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):546-52. PubMed ID: 19464922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is anterior mitral valve leaflet length important in outcome of septal myectomy for obstructive hypertrophic cardiomyopathy?
    Lentz Carvalho J; Schaff HV; Nishimura RA; Ommen SR; Geske JB; Lahr BD; Newman DB; Dearani JA
    J Thorac Cardiovasc Surg; 2023 Jan; 165(1):79-87.e1. PubMed ID: 33632527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?
    Knyshov G; Lazoryshynets V; Rudenko K; Kravchuk B; Beshlyaga V; Zalevsky V; Rasputnyak O; Batsak B
    Interact Cardiovasc Thorac Surg; 2013 Jan; 16(1):5-9. PubMed ID: 23027595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transapical beating-heart septal myectomy for recurrent left ventricular outflow tract obstruction after septal reduction therapy in hypertrophic obstructive cardiomyopathy.
    Li J; Li C; Wei X
    Eur J Cardiothorac Surg; 2023 Sep; 64(3):. PubMed ID: 37665748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Hypertrophic Obstructive Cardiomyopathy Patients and Preserved Left Ventricular Ejection Fraction.
    Tower-Rader A; Betancor J; Popovic ZB; Sato K; Thamilarasan M; Smedira NG; Lever HM; Desai MY
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29054839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial results of combined anterior mitral leaflet extension and myectomy in patients with obstructive hypertrophic cardiomyopathy.
    Kofflard MJ; van Herwerden LA; Waldstein DJ; Ruygrok P; Boersma E; Taams MA; Ten Cate FJ
    J Am Coll Cardiol; 1996 Jul; 28(1):197-202. PubMed ID: 8752814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabry disease in cardiology practice: Literature review and expert point of view.
    Hagège A; Réant P; Habib G; Damy T; Barone-Rochette G; Soulat G; Donal E; Germain DP
    Arch Cardiovasc Dis; 2019 Apr; 112(4):278-287. PubMed ID: 30826269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.